Company Analysis

Zoetis Inc. (ZTS)

NYSE: ZTS · Pharmaceutical Preparations · Parsippany, NJ · filing with the SEC since 2012
Grade6.7
◀ Past 8.4● Present 7.0▶ Future 4.5

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

395 patents granted to the 23 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Zoetis Inc.’s names, not what it holds today.

Patents granted
395
389 utility, 4 design, 2 reissue, 1976 to Dec 31, 2025
Granted in 2025
26
Against 24 in 2024 and 12 in 2023
Applications published
404
30 of them in 2025
Names they are printed under
23
a subsidiary, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals58
Analysis of biological materials14
Other special machines7
Biotechnology7
Measurement7
Organic fine chemistry7
Chemical engineering4
Handling2
Medical technology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name23 counted
Zoetis Services LLC a subsidiary
named as the applicant on its applications, in US
0 granted
225 published
Zoetis Services LLC a subsidiary
US, as the owner printed on each patent
218 granted
6 published
Embrex, Inc. a subsidiary
US, as the owner printed on each patent
65 granted
20 published
Abaxis, Inc. a subsidiary
US, as the owner printed on each patent
60 granted
15 published
Zoetis LLC its own name
US, as the owner printed on each patent
26 granted
18 published
Zoetis LLC its own name
named as the applicant on its applications, in US
0 granted
37 published
ABAXIS, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
31 published
Alpharma, LLC a subsidiary
US, as the owner printed on each patent
2 granted
16 published
Pharmaq AS a subsidiary
named as the applicant on its applications, in NO
0 granted
9 published
JUROX PTY LTD a subsidiary
AU, as the owner printed on each patent
5 granted
3 published
Pharmaq AS a subsidiary
NO, as the owner printed on each patent
6 granted
0 published
Platinum Performance, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
6 published
Zoetis Belgium S.A a subsidiary
BE, as the owner printed on each patent
6 granted
0 published
JUROX PTY LTD a subsidiary
named as the applicant on its applications, in AU
0 granted
4 published
ZOETIS DENMARK APS a subsidiary
DK, as the owner printed on each patent
3 granted
1 published
BASEPAWS a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
ZOETIS CANADA INC. a subsidiary
CA, as the owner printed on each patent
3 granted
0 published
Zoetis Belgium S.A. a subsidiary
named as the applicant on its applications, in BE
0 granted
3 published
AL Pharma, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
Adivo GmbH a subsidiary
DE, as the owner printed on each patent
1 granted
1 published
adivo GmbH a subsidiary
named as the applicant on its applications, in DE
0 granted
2 published
VIRTUAL RECALL LIMITED a subsidiary
GB, as the owner printed on each patent
0 granted
1 published
ZOETIS CANADA INC. a subsidiary
named as the applicant on its applications, in CA
0 granted
1 published
Names not counted (2)
Alpharma, LLC
Most of its patents print NO; this name counts in US. 1 granted and 2 published under it are not counted.
Zoetis Belgium S.A.
Most of its patents print US; this name counts in BE. 1 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 16, 202512,497,459Nucleic acids encoding canine anti-NGF antibodies and methods thereofPharmaceuticalsZoetis Services LLC
Nov 4, 202512,458,001Singulating device for organismsOther special machinesZoetis Services LLC
Oct 14, 202512,440,556Genetically modified cell line for production of Marek's disease virus vaccine and methods of making and using the sameBiotechnologyZoetis Services LLC
Sep 23, 202512,419,941Poultry drinking water-based vaccine delivery system and methodPharmaceuticalsZoetis Services LLC
Aug 19, 202512,390,441Immunomodulating o-het/aryl azalidesPharmaceuticalsZoetis Services LLC
Aug 19, 202512,390,440Immunomodulating trifluoromethyl-aminal azalidesPharmaceuticalsZoetis Services LLC
Aug 5, 202512,378,233Immunomodulating azalidesOrganic fine chemistryZoetis Services LLC
Jul 8, 202512,350,328Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horsesPharmaceuticalsZoetis Services LLC
Jul 1, 202512,344,659Canine antibody librariesBiotechnologyAdivo GmbH
Jul 1, 202512,343,402Method of determining the identity and/or amount of an anti-IL-31 antibody in a samplePharmaceuticalsZoetis Services LLC
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 30, 20252025/0332243METHODS OF MANUFACTURING PORCINE ENDOGENOUS RETROVIRUS (PERV) FREE ANIMAL HEALTH VACCINESPharmaceuticalsZoetis Services LLC
Oct 30, 20252025/0332242PORCINE ENDOGENOUS RETROVIRUS (PERV)-FREE PORCINE CIRCOVIRUS TYPE 2D-BASED VACCINES AND METHODS OF USEPharmaceuticalsZoetis Services LLC
Oct 23, 20252025/0325685PEPTIDE VACCINES AGAINST INTERLEUKIN-31PharmaceuticalsZoetis Services LLC
Oct 9, 20252025/0312431VACCINES AGAINST MORITELLA VISCOSAPharmaceuticalsZoetis Services LLC
Sep 25, 20252025/0295752VACCINE AGAINST INFECTIOUS BRONCHITISPharmaceuticalsZoetis Services LLC
Sep 25, 20252025/0295732COMPOSITIONS AND METHODS FOR ACTIVATING INNATE IMMUNITYPharmaceuticalsZoetis Services LLC
Sep 4, 20252025/0276967HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASESOrganic fine chemistryZoetis LLC
Aug 28, 20252025/0270661NOVEL FISH TOTIVIRUSBiotechnologyPharmaq AS
Jul 24, 20252025/0236616IMMUNOMODULATING AZALIDESOrganic fine chemistryZoetis Services LLC
Jun 26, 20252025/0206832Anti-NGF Antibodies and Methods ThereofPharmaceuticalsZoetis Services LLC
What it applied for, 2024 to 2025: Pharmaceuticals 32 · Biotechnology 11 · Organic fine chemistry 4 · Other special machines 3 · Analysis of biological materials 2 · Medical technology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ZTS · research, not advice